Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
darbepoetin alfa
darbepoetin alfa
Brand names: Aranesp, Aranesp Albumin Free
| Form | Strength |
|---|---|
| SOLUTION, INJECTABLE | 25 mcg/0.42 mL; 40 mcg/0.4 mL; 60 mcg/0.3 mL; 100 mcg/0.5 mL; 100 mcg/mL; 150 mcg/0.3 mL; 200 mcg/0.4 mL; 300 mcg/0.6 mL; 300 mcg/mL |
Last updated: Jan. 9, 2024
- Black Box Warning: Mortality, serious CV events, tumor progression or recurrence
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.